Free Trial

Vanda Pharmaceuticals (VNDA) Stock Forecast & Price Target

Vanda Pharmaceuticals logo
$4.32 -0.12 (-2.70%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$4.32 +0.00 (+0.12%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Vanda Pharmaceuticals - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
2

Based on 2 Wall Street analysts who have issued ratings for Vanda Pharmaceuticals in the last 12 months, the stock has a consensus rating of "Strong Buy." Out of the 2 analysts, 1 has given a buy rating, and 1 has given a strong buy rating for VNDA.

Consensus Price Target

$16.50
281.94% Upside
According to the 2 analysts' twelve-month price targets for Vanda Pharmaceuticals, the average price target is $16.50. The highest price target for VNDA is $20.00, while the lowest price target for VNDA is $13.00. The average price target represents a forecasted upside of 281.94% from the current price of $4.32.
Get the Latest News and Ratings for VNDA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Vanda Pharmaceuticals and its competitors.

Sign Up

VNDA Analyst Ratings Over Time

TypeCurrent Forecast
5/22/24 to 5/22/25
1 Month Ago
4/22/24 to 4/22/25
3 Months Ago
2/22/24 to 2/21/25
1 Year Ago
5/23/23 to 5/22/24
Strong Buy
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
N/A
Buy
1 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
N/A
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
N/A
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
N/A
Consensus Price Target$16.50$16.50$16.50N/A
Forecasted Upside281.94% Upside274.15% Upside272.46% UpsideN/A
Consensus Rating
Strong Buy
Buy
Buy
N/A

VNDA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

VNDA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Vanda Pharmaceuticals Stock vs. The Competition

TypeVanda PharmaceuticalsMedical CompaniesS&P 500
Consensus Rating Score
3.50
2.81
2.54
Consensus RatingStrong BuyModerate BuyModerate Buy
Predicted Upside281.94% Upside4,168.13% Upside15.74% Upside
News Sentiment Rating
Neutral News

See Recent VNDA News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/14/2025Cantor Fitzgerald
3 of 5 stars
Olivia Brayer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight$13.00+232.06%
5/7/2025HC Wainwright
1 of 5 stars
Raghuram Selvaraju
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00 ➝ $20.00+357.67%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 04:33 AM ET.


VNDA Forecast - Frequently Asked Questions

According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Vanda Pharmaceuticals is $16.50, with a high forecast of $20.00 and a low forecast of $13.00.

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Vanda Pharmaceuticals in the last twelve months. There is currently 1 buy rating and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "strong buy" VNDA shares.

According to analysts, Vanda Pharmaceuticals's stock has a predicted upside of 281.94% based on their 12-month stock forecasts.

Over the previous 90 days, Vanda Pharmaceuticals's stock had 1 upgrade by analysts.

Vanda Pharmaceuticals has been rated by research analysts at Cantor Fitzgerald, and HC Wainwright in the past 90 days.

Analysts like Vanda Pharmaceuticals more than other "medical" companies. The consensus rating for Vanda Pharmaceuticals is Strong Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how VNDA compares to other companies.


This page (NASDAQ:VNDA) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners